<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Pentoxifylline was first registered (in Germany) 20 years ago </plain></SENT>
<SENT sid="1" pm="."><plain>Then its main action seemed to be vasodilatation </plain></SENT>
<SENT sid="2" pm="."><plain>Later hemorheological effect, in particular on red cell deformability, were found </plain></SENT>
<SENT sid="3" pm="."><plain>Independent of its pharmacological effects, the clinical effectiveness in peripheral and <z:e sem="disease" ids="C0007774" disease_type="Disease or Syndrome" abbrv="">cerebral arterial disease</z:e> is well established </plain></SENT>
<SENT sid="4" pm="."><plain>More recently its action on leucocytes has gained interest </plain></SENT>
<SENT sid="5" pm="."><plain>Both rheological and biochemical changes have been reported </plain></SENT>
<SENT sid="6" pm="."><plain>This new knowledge will create new indications for pentoxifylline within the near future which possibly will go beyond angiology </plain></SENT>
</text></document>